Cargando…

Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports

BACKGROUND: Primary cutaneous amyloidosis (PCA) is a chronic metabolic skin disease that has a detrimental impact on physical and mental health. It appears as mossy papules and severe itching, which is long-term and recurrent. Traditional treatments are unsatisfactory, especially for refractory case...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yan-Qian, Liu, Zhao-Yang, Wei, Guo, Zhang, Chun-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297393/
https://www.ncbi.nlm.nih.gov/pubmed/36051117
http://dx.doi.org/10.12998/wjcc.v10.i20.7147
_version_ 1784750466097217536
author Su, Yan-Qian
Liu, Zhao-Yang
Wei, Guo
Zhang, Chun-Min
author_facet Su, Yan-Qian
Liu, Zhao-Yang
Wei, Guo
Zhang, Chun-Min
author_sort Su, Yan-Qian
collection PubMed
description BACKGROUND: Primary cutaneous amyloidosis (PCA) is a chronic metabolic skin disease that has a detrimental impact on physical and mental health. It appears as mossy papules and severe itching, which is long-term and recurrent. Traditional treatments are unsatisfactory, especially for refractory cases. Fire needle therapy, which is widely used in China, has shown good clinical efficacy, as well as advantages concerning safety and cost. Clinical reports about fire needle treatment of this disease are few at present. CASE SUMMARY: We report two older men who had developed maculopapules with itchiness on the trunk and arms for more than 10-15 years. Due to the dermatopathological findings, PCA was our primary consideration. They received topical halometasone cream and pretreatment with fire needle for 8-16 wk. Both patients showed significant improvement of lesions. Neither patient had recurrence with a minimum of 2 years of follow-up. CONCLUSION: Topical halometasone cream and pretreatment with fire needle could be a fast, safe, and economic treatment for PCA.
format Online
Article
Text
id pubmed-9297393
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-92973932022-08-31 Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports Su, Yan-Qian Liu, Zhao-Yang Wei, Guo Zhang, Chun-Min World J Clin Cases Case Report BACKGROUND: Primary cutaneous amyloidosis (PCA) is a chronic metabolic skin disease that has a detrimental impact on physical and mental health. It appears as mossy papules and severe itching, which is long-term and recurrent. Traditional treatments are unsatisfactory, especially for refractory cases. Fire needle therapy, which is widely used in China, has shown good clinical efficacy, as well as advantages concerning safety and cost. Clinical reports about fire needle treatment of this disease are few at present. CASE SUMMARY: We report two older men who had developed maculopapules with itchiness on the trunk and arms for more than 10-15 years. Due to the dermatopathological findings, PCA was our primary consideration. They received topical halometasone cream and pretreatment with fire needle for 8-16 wk. Both patients showed significant improvement of lesions. Neither patient had recurrence with a minimum of 2 years of follow-up. CONCLUSION: Topical halometasone cream and pretreatment with fire needle could be a fast, safe, and economic treatment for PCA. Baishideng Publishing Group Inc 2022-07-16 2022-07-16 /pmc/articles/PMC9297393/ /pubmed/36051117 http://dx.doi.org/10.12998/wjcc.v10.i20.7147 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Su, Yan-Qian
Liu, Zhao-Yang
Wei, Guo
Zhang, Chun-Min
Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title_full Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title_fullStr Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title_full_unstemmed Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title_short Topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: Two case reports
title_sort topical halometasone cream combined with fire needle pre-treatment for treatment of primary cutaneous amyloidosis: two case reports
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297393/
https://www.ncbi.nlm.nih.gov/pubmed/36051117
http://dx.doi.org/10.12998/wjcc.v10.i20.7147
work_keys_str_mv AT suyanqian topicalhalometasonecreamcombinedwithfireneedlepretreatmentfortreatmentofprimarycutaneousamyloidosistwocasereports
AT liuzhaoyang topicalhalometasonecreamcombinedwithfireneedlepretreatmentfortreatmentofprimarycutaneousamyloidosistwocasereports
AT weiguo topicalhalometasonecreamcombinedwithfireneedlepretreatmentfortreatmentofprimarycutaneousamyloidosistwocasereports
AT zhangchunmin topicalhalometasonecreamcombinedwithfireneedlepretreatmentfortreatmentofprimarycutaneousamyloidosistwocasereports